APATINIB

Clinical trials for APATINIB explained in plain language.

Never miss a new study

Get alerted when new APATINIB trials appear

Sign up with your email to follow new studies for APATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy shows promise for tough bile duct cancer

Disease control Completed

This study tested a three-drug combination for people with advanced bile duct cancer that worsened after standard chemotherapy. The treatment included chemo beads placed directly into the liver tumor, a targeted therapy pill (apatinib), and an immunotherapy drug (PD-1 antibody). …

Matched conditions: APATINIB

Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control

Last updated Apr 30, 2026 15:52 UTC

APATINIB

Get alerted when new APATINIB trials appear

New combo therapy shows promise for tough bile duct cancer